Neudesin in obesity and type 2 diabetes mellitus: the effect of acute fasting and weight reducing interventions
Status PubMed-not-MEDLINE Jazyk angličtina Země Nový Zéland Médium electronic-ecollection
Typ dokumentu časopisecké články
PubMed
30992678
PubMed Central
PMC6445223
DOI
10.2147/dmso.s193259
PII: dmso-12-423
Knihovny.cz E-zdroje
- Klíčová slova
- acute fasting, bariatric surgery, energy homeostasis, neudesin, obesity, type 2 diabetes mellitus, weight reduction,
- Publikační typ
- časopisecké články MeSH
CONTEXT: Neudesin has recently been identified as a novel regulator of energy expenditure in experimental animals; however, its role in humans remains unexplored. OBJECTIVE: The aim of this study was to assess the effects of obesity and type 2 diabetes mellitus (T2DM) along with selected weight reducing interventions on serum neudesin levels and adipose tissue mRNA expression. PATIENTS AND METHODS: Fifteen obese subjects with T2DM undergoing endoscopic duodenal-jejunal bypass liner (DJBL) implantation, 17 obese subjects (11 with T2DM, 6 without T2DM) scheduled for gastric plication (GP), 15 subjects with functional hypoglycemia subjected to 72-hour acute fasting (AF), and 12 healthy controls were included in the study. RESULTS: Baseline neudesin levels were comparable between all groups. DJBL increased neudesin at 6 and 10 months after the procedure (1.77±0.86 vs 2.28±1.27 vs 2.13±1.02 ng/mL, P=0.001 for baseline vs 6 vs 10 months) along with reduction in body weight and improvement of HbA1c without any effect on neudesin mRNA expression in subcutaneous adipose tissue. Conversely, GP did not affect neudesin levels despite marked reduction in body weight and improvement of HbA1c. In contrast, AF decreased neudesin levels during the entire period (1.74±0.54 vs 1.46±0.48 ng/mL, P=0.001 for baseline vs 72 hours) with no impact of subsequent re-alimentation on neudesin concentrations. CONCLUSION: Neudesin levels are differentially regulated during AF and chronic weight reduction induced by DJBL or GP. Further studies are needed to assess its possible significance in energy homeostasis regulation in humans.
Department of Surgery OB Clinic Prague Czech Republic
Diabetes Centre Institute for Clinical and Experimental Medicine Prague Czech Republic
Zobrazit více v PubMed
O’Rahilly S. Science, medicine, and the future. non-insulin dependent diabetes mellitus: the gathering storm. BMJ. 1997;314(7085):955–959. PubMed PMC
Hruby A, Hu FB. The epidemiology of obesity: a big picture. Pharmacoeconomics. 2015;33(7):673–689. PubMed PMC
Reaven G. Metabolic syndrome: pathophysiology and implications for management of cardiovascular disease. Circulation. 2002;106(3):286–288. PubMed
Reaven G. Syndrome X. Curr Treat Options Cardiovasc Med. 2001;3(4):323–332. PubMed
Seoane-Collazo P, Fernø J, Gonzalez F, et al. Hypothalamic-autonomic control of energy homeostasis. Endocrine. 2015;50(2):276–291. PubMed
Lau J, Herzog H. CART in the regulation of appetite and energy homeo-stasis. Front Neurosci. 2014;8:313. PubMed PMC
Farooqi IS, O’Rahilly S. 20 years of leptin: human disorders of leptin action. J Endocrinol. 2014;223(1):T63–T70. PubMed
Ohta H, Kimura I, Konishi M, Itoh N. Neudesin as a unique secreted protein with multi-functional roles in neural functions, energy metabolism, and tumorigenesis. Front Mol Biosci. 2015;2:24. PubMed PMC
Kimura I, Yoshioka M, Konishi M, Miyake A, Itoh N. Neudesin, a novel secreted protein with a unique primary structure and neurotrophic activity. J Neurosci Res. 2005;79(3):287–294. PubMed
Kimura I, Nakayama Y, Konishi M, et al. Functions of MAPR (membrane-associated progesterone receptor) family members as heme/ steroid-binding proteins. Curr Protein Pept Sci. 2012;13(7):687–696. PubMed
Han KH, Lee SH, Ha SA, et al. The functional and structural characterization of a novel oncogene GIG47 involved in the breast tumorigenesis. BMC Cancer. 2012;12(1):274. PubMed PMC
Kimura I, Nakayama Y, Zhao Y, Konishi M, Itoh N. Neurotrophic effects of neudesin in the central nervous system. Front Neurosci. 2013;7:111. PubMed PMC
Byerly MS, Swanson RD, Semsarzadeh NN, et al. Identification of hypothalamic neuron-derived neurotrophic factor as a novel factor modulating appetite. Am J Physiol Regul Integr Comp Physiol. 2013;304(12):R1085–R1095. PubMed PMC
Novais A, Ferreira AC, Marques F, et al. Neudesin is involved in anxiety behavior: structural and neurochemical correlates. Front Behav Neuro-sci. 2013;7:119. PubMed PMC
Ohta H, Konishi M, Kobayashi Y, et al. Deletion of the neurotrophic factor neudesin prevents diet-induced obesity by increased sympathetic activity. Sci Rep. 2015;5:10049. PubMed PMC
Sun WW, Zhu P, Shi YC, et al. Current views on neuropeptide Y and diabetes-related atherosclerosis. Diab Vasc Dis Res. 2017;14(4):277–284. PubMed
Schwartz MW, Woods SC, Porte D, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature. 2000;404(6778):661–671. PubMed
Saltiel AR, Kahn CR. Insulin signalling and the regulation of glucose and lipid metabolism. Nature. 2001;414(6865):799–806. PubMed
Kimura I, Konishi M, Asaki T, et al. Neudesin, an extracellular heme-binding protein, suppresses adipogenesis in 3T3-L1 cells via the MAPK cascade. Biochem Biophys Res Commun. 2009;381(1):75–80. PubMed
Haluzík M, Kratochvílová H, Haluzíková D, Mráz M. Gut as an emerging organ for the treatment of diabetes: focus on mechanism of action of bariatric and endoscopic interventions. J Endocrinol. 2018;237(1):R1–R17. PubMed
Madsbad S, Dirksen C, Holst JJ. Mechanisms of changes in glucose metabolism and bodyweight after bariatric surgery. Lancet Diabetes Endocrinol. 2014;2(2):152–164. PubMed
Kratochvilova H, Lacinova Z, Klouckova J, et al. Neudesin, a Novel Regulator of Energy Metabolism in Obesity and Type 2 Diabetes Mellitus—The Effect of Acute Fasting and Endoscopic Duodenal-Jejunal Bypass Liner Implantation [abstract] Diabetes. 2018;67(Suppl 1) Available from: http://diabetes.diabetesjournals.org/content/67/Supplement_1/2449-PUB.